CASI Pharmaceuticals
CASI
#11090
Rank
NZ$7.56 M
Marketcap
NZ$0.37
Share price
0.00%
Change (1 day)
-84.54%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): NZ-$4.70

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.91. In 2021 the company made an earnings per share (EPS) of NZ-$4.83 an increase over its 2020 EPS that were of NZ-$7.75.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$4.70-2.5%
2021NZ-$4.83-37.76%
2020NZ-$7.75-8.96%
2019NZ-$8.5250%
2018NZ-$5.6877.78%
2017NZ-$3.19-7.42%
2016NZ-$3.45-11.63%
2015NZ-$3.90-75.56%
2014NZ-$15.97309.09%
2013NZ-$3.90-72.84%
2012NZ-$14.3768.75%
2011NZ-$8.52-48.94%
2010NZ-$16.68-19.66%
2009NZ-$20.76-62.01%
2008NZ-$54.64-0%
2007NZ-$54.64-62.67%
2006NZ-$146.36134.38%
2005NZ-$62.45-13.51%
2004NZ-$72.21-44.78%
2003NZ-$130.75-62.36%
2002NZ-$347.37-26.14%
2001NZ-$470.31-20.72%
2000NZ-$593.2613.43%
1999NZ-$523.01150.47%
1998NZ-$208.8194.55%
1997NZ-$107.3327.91%
1996NZ-$83.92